SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 57.89+1.8%3:15 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who started this subject11/6/2001 10:03:08 AM
From: aknahow  Read Replies (1) of 52153
 
Cash about to get trashier! Those biotech companies, that sold stock, which some investors think will be worth, at least, 100% more in five years, will now earn under 2%, per year, on the funds raised.

Far from automatically indicating value, huge cash balances will come to be seen as a sign that such companies lack worthwhile projects or at least the inability to bring products into development. Not saying this perception will be correct. Just that it will overtake the cash represents value concept.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News